FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| EMD-56551, 133109-86-1, EMD-56551 Intermediate 83696-90-6, stock 653.5g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| EMD-56551, 133109-86-1, EMD-56551 Intermediate 38212-30-5, stock 620.5g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
| EMD-56551, 133109-86-1, EMD-56551 Intermediate 133735-41-8, stock 750.2g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| EMD-56551, 133109-86-1, EMD-56551 Intermediate 133109-86-1, stock 174.9g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
